The market for pre-filled syringes (PFS) is experiencing rapid growth, propelled by increasing demand for innovative biologics and a preference for self-administration treatment options that offer enhanced convenience. This surge in demand for PFS is driving advancements in packaging design aimed at improving usability and enhancing patient safety.

Nevertheless, catering to the packaging requirements of the expanding biologics sector poses numerous challenges. These include the careful selection of appropriate packaging solutions for each project and potential investment of significant capital to upgrade manufacturing facilities. Consequently, the adoption of new PFS packaging and integration of emerging technologies may appear daunting, especially for smaller biologics developers.

In this article, Geert Vleugels, General Manager NL at Tjoapack, explores the factors driving innovation in PFS packaging and underscores the importance of collaborating with packaging specialists to deliver therapies that prioritize patient needs and safety.

‍